MBRX - 1.76 Pre-market now at 1.98/2.00 Moleculin Expands Leukemia Development Portfolio with Immuno-Stimulating STAT3 Inhibitor http://stockcharts.com/c-sc/sc?s=MBRX&p=D&b=5&g=0&i=t05031384518&r=1515592247628 http://stockcharts.com/c-sc/sc?s=MBRX&p=W&b=5&g=0&i=t32659227666&r=1515592269567